chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Minor illnesses several times after 2nd vaccine then developed shingles mid July 2021 (3 months after 2nd shot). Shingles quickly turned into viral meningitis with varicella zoster virus by PCR found in spinal tap. Staff were concerned about immune system as is very unusual for a healthy person with normal immune system to develop meningitis with varicella zoster virus. Someone also noted though that they had another case of it just a few weeks prior.  It may not have been related to covid vaccine but it seemed worth reporting in case there is a link.
This spontaneous report was received from a certified medical assistant referring to unknown age and gender patient. No information regarding the patient's medical history, concurrent conditions and concomitant medications were not provided. On 01-AUG-2016 the patient was vaccinated with improperly stored GARDASIL 9 (dose and route of administration were not reported); lot no. M003659 EXP 20-SEP-2017 or lot no. L025737 EXP 28-JUL-2017. No adverse event was reported. This is one of several reports received from the same reporter. Additional information has been requested.
ringing in her ears; This is a spontaneous report from a contactable physician. An 8-decade-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced ringing in her ears on an unspecified date with outcome of unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained. No further information is expected.
Large area of erythema and mild induration over L thigh, onset 1 day after vaccination and progressing over 3 days.  Fever x 3 days.
Light chain increased; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LIGHT CHAIN ANALYSIS INCREASED (Light chain increased) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple myeloma (in remission).    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced LIGHT CHAIN ANALYSIS INCREASED (Light chain increased). At the time of the report, LIGHT CHAIN ANALYSIS INCREASED (Light chain increased) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Light chain analysis: increased (High) Increases.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included unspecified multiple immunosuppressants. Treatment information was not provided. Patient received second dose of vaccine in ??-FEB-2021.   This case was linked to MOD-2021-085987 (Patient Link).   Reporter did not allow further contact
Reports tingling and electric shock pain from the L finger up to the site of injection; 7cm erythema surrounded the site of injection; warm to touch; very tender to palpation along the L arm;
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), on 31Mar2022 at 11:00 as dose 4 (booster), single (Lot number: FK9893) at the age of 64 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "COPD" (unspecified if ongoing); "heart disease" (unspecified if ongoing). The patient had no known allergies. Concomitant medications included: BREZTRI AEROSPHERE, start date: 25Jan2022; LEXAPRO, start date: 29Jul2020; ZETIA, start date: 04Jun2020; POTASSIUM CHLORIDE, start date: 27Apr2020; PROAIR HFA resp inhalation, start date: 31Mar2020; LIPITOR, start date: 31Mar2020; VIBRAMYCIN [DOXYCYCLINE HYCLATE], start date: 30Mar2020; K-DUR, start date: 27Apr2020. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of covid-19, which included anti viral COVID 19 treatment with Paxlovid from 18Aug2022 to 22Aug2022.
broke out with a body rash all over the body; nasal drip; I Tested positive on 23rd, in bed for 16 days; I Tested positive on 23rd, in bed for 16 days; This is a spontaneous report from a non-contactable consumer. A 62-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date unspecified), via an unspecified route of administration on 15Mar2021 as single dose for COVID-19 immunization. Medical history included asthma and Covid-19 from same time a year ago, 15Mar2020 to middle of Apr2020 and it was worse the first time in 2020. The patient's concomitant medications were not reported. The patient had first dose of the vaccine on 15Mar2020, and she was due for the 2nd dose on 12Apr2020. On 23Mar2021, the patient tested positive, and was in bed for 16 days. The patient reported that she felt better, but broke out with a body rash all over the body on an unspecified date. The patient also had a nasal drip but that's because she had asthma. She reported she had no fever for the last 5 days, now this viral thing came up, her primary care doctor thought it was reaction to something she ate, her dermatologist said that they were seeing covid cases that were  presenting with rashes throughout their body. Her dermatologist said that this rash was the body's way of getting rid of the virus and was trying to get out of her system. This rash comes and goes when she woke up it wasn't there, but with activity it picked up again. She don't know what the whole time frame may be it could take up to 6 weeks to get out of the body. The patient was wondering if she can get the second dose of the vaccine and if there was a guidance on time frame for the second dose. Outcome of events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Received ZOSTAVAX (L) upper arm sub-q on 6/1/16. Presents on 6/3/16 with area of erythema, tenderness approx. 4 1/2" x 3" at injection site. Treated with KEFLEX 500 mg one TID x 10 days.
A 13-year-old female patient was in the observation area waiting for her time to be discharged and reported feeling dizzy, blurred vision and back pain. He was transferred to the incident observation area and his vital signs were taken, which were: 74 Pulse, 36.5C Temperature, 98% SpO2. 105/25 mmHg B/P, 16 RESP and 106 Dextro. Case was consulted with Doctor and she refers to giving the patient 2 500mg Acetaminophen tablets. At 6:55 pm the patient reports feeling well.
Local reaction of large muscle swelling, redness and warmth that lasted 24 hours. Heat reduced swelling to "chicken egg-size" X 48 more hours. Warmth persisted. Five days, post vax, has area of bruising at site but warmth reduced and swelling minimal.
He received influenza immunization at local pharmacy.  Approximately three to four hours after injection, he felt chilled and noted shaking in bilateral arms.  He states that his legs were weak, such that he fell while walking to the restroom.  His son helped him get back to bed and he was able to go to sleep.  He reports episode of urinary incontinence during the night, which is unusual occurrence for him.  He states the next morning he was able to rise and weight bear, though he did not quite feel like himself for a couple of days.
Initial misuse report received from a healthcare professional on 05 April 2013. A dose of DAPTACEL was given to 13-year-old patient instead of ADACEL. No adverse event was reported. List of documents held by sender: none.
The patient who was vaccinated "a while back", recently was in contact with another child with chicken pox. Subsequently, the patient developed a very mild case of chicken pox, including one vesicle. Unspecified medical attention was sought. Additional information has been requested.
Her arm is swollen since Thursday; This booster really kicked, her around; flu-like symptoms; The left shoulder where the shot was administered, she has a knot in her arm; The left shoulder where the shot was administered, she has a knot in her arm. It's really red.; She had body aches; She was really really sick; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (This booster really kicked, her around), INFLUENZA LIKE ILLNESS (flu-like symptoms), ILLNESS (She was really really sick), VACCINATION SITE INDURATION (The left shoulder where the shot was administered, she has a knot in her arm) and VACCINATION SITE ERYTHEMA (The left shoulder where the shot was administered, she has a knot in her arm. It's really red.) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Pfizer ((lot EN6207)) on 16-Mar-2021 and Pfizer ((lot EN0153)) on 07-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer; and Sickness with Pfizer.    On 30-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced ILLNESS (She was really really sick). On 29-Dec-2021, the patient experienced VACCINATION COMPLICATION (This booster really kicked, her around), INFLUENZA LIKE ILLNESS (flu-like symptoms), VACCINATION SITE INDURATION (The left shoulder where the shot was administered, she has a knot in her arm), VACCINATION SITE ERYTHEMA (The left shoulder where the shot was administered, she has a knot in her arm. It's really red.) and MYALGIA (She had body aches). On 30-Dec-2021, the patient experienced VACCINATION SITE SWELLING (Her arm is swollen since Thursday). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) from 29-Dec-2021 to 30-Dec-2021 at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (This booster really kicked, her around), INFLUENZA LIKE ILLNESS (flu-like symptoms), ILLNESS (She was really really sick) and MYALGIA (She had body aches) outcome was unknown and VACCINATION SITE INDURATION (The left shoulder where the shot was administered, she has a knot in her arm), VACCINATION SITE ERYTHEMA (The left shoulder where the shot was administered, she has a knot in her arm. It's really red.) and VACCINATION SITE SWELLING (Her arm is swollen since Thursday) had not resolved.            She put alcohol with cotton swabs on her arm. Concomitant medication use was unknown
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) had not resolved.            No Concomitant medications were provided No Treatment information provided   This case was linked to MOD-2021-030189 (Patient Link).
January 31-Feb1 Fever to 102.7, muscle rigidity, spasm and pain, bone pain over entire body lasting 7 hours overnight, tylenol 1000mg fever broke and pain subsided.  Wanted to call 911.  Feb 1st muscle pain increased during the morning and by noon fever of 102.5 with extreme fatigue, tylenol 1000 mg, unable to work. Injection site intense pain radiating down to wrist. Feb1st overnight sweats and bone pain, muscle pain tylenol 1000mg, injection site pain and redness appearing similar to a sunburn near injection site, swelling of lymph nodes under right arm with pain.  Headache, moderate to intense. Feb 2nd fever to 100.5 with moderation of the above symptoms. Asthma chest tightness, asthma related productive cough. Tylenol 500mg every 3-4 hours, working from home.  Headache continues moderate level. Feb 3rd, no fever all symptoms continue with injection site pain, new increased asthma related wheezing. Tylenol 500 mg every 4 hours.  Headache continues with fatigue.   Feb 4th, no fever, symptoms moderating, asthma and allergy symptoms increasing.  Fatigue increasing.  Itching of injection site. Feb 5-current.  No fever pain in injection site and lymph node area is moderating, still with  Fatigue, Headache, Asthma and allergy symptoms staying steady with period of increased levels.  Tylenol  500 mg 6-8 times a day.
No additional AE information. No PQC reported; Incorrect storage of drug; This spontaneous report as received from a medical assistant concerning a patient of unknown age and gender. There was no information about the patient's medical history, concurrent conditions or concomitant medication.  On an 03-MAR-2021, the patient was vaccinated with an improperly stored dose of   dose pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), prefilled syringe, 0.5mllliliter,  lot # T033369, expiration date: 26-MAY-2022,  for prophylaxis ((dose number, and  route of administration were not reported).     The administered dose of the vaccine experienced a temperature excursion 11 degrees Celsius  for 1 hour, as recorded by a data logger. No additional adverse evnt  information. No product quality complaint was involved. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T033369; expirationdate: 26-MAY-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Pt woke mother up with c/o vomiting in AM and decrease appetite noted. Pt with fever of 100.3 with rash in PM 08/13/2010 on abdomen and back. Red and raised rash with c/o itching.
Tired; Inflammation in her joint particularly in her hand; Swollen arm; Joints were really painful; Arm was a tad sore; A spontaneous report was received from a Consumer concerning a 72-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events tired, inflammation in her joint particularly in her hand, swollen arm, joints were really painful and arm was a tad sore.  The patient's medical history was not provided. Concomitant medications reported were B12, rosuvastatin and omeprazole, drug used for unknown indication.  On 11 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 00053740) in the left arm for prophylaxis of COVID-19 infection.  On 15 Jan 2021, the patient experienced the events tired, inflammation in her joint particularly in her hand, swollen arm, joints were really painful and arm was a tad sore.  Treatment details were not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, tired, inflammation in her joint particularly in her hand, swollen arm, joints were really painful and arm was a tad sore was considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
had an inflamed lymph node after the vaccine; This is a spontaneous report from a contactable consumer (Pfizer colleague). A female patient of an unspecified age received bnt162b2 (BNT162B2; solution for injection; unknown lot number and expiration date), via an unspecified route of administration on an unspecified date at single dose for Covid-19 vaccination. The patient's medical history and concomitant medications were not reported. The reporter stated that her family friend reported that she had an inflamed lymph node after the vaccine. She said that she already did the vsafe but didn't say anything about the reaction to the vaccine. The patient inquired if there was another website that she needs to report to which the reporter replied that VAERS is the correct place to report. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Patient states that she began to feel tired 12/27/21 evening.  She noticed redness and pain at the site a few hours after immunization as well.  Swelling in her armpit started 12/28/21 and had not gotten better as of 12/29/21.  She was also having sinus drainage.
No known adverse events.  The patient was injected with the diluent instead of the pediatric pfizer vaccine.
The vaccine did not prevent shingles as intended; persistent strain of herpes zoster or shingles; Information has been received from a lawyer concerning a case in litigation and refers to a patient of an unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On or about 17-MAY-2013, the patient was inoculated with zoster vaccine live (ZOSTAVAX) vaccine (dose, route of administration, vaccination site, lot # and expiry date were not specified) by a physician as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 25-JUL-2016, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX) vaccine, and/or despite receiving zoster vaccine live (ZOSTAVAX) for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and would continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. The causality was related.
Narrative:  Patient reported that he had significant arm pain at areas of vaccination administration and flu-like symptoms which lasted for 3 days approx 6 days after receiving both influenza vaccination and COVID-19 booster dose were given in the same arm on the same day. Patient wanted to reported ADR, did not pursue COVID testing, no additional symptoms.
This spontaneous report was received from a pharmacist via a company representative refers to a patient of unknown demographics. No relevant medical history of the patient was reported. On an unknown date the patient was vaccinated with PNEUMOVAX 23 dose 2 (strength, route, lot number and expiration date were not reported). There were no concomitant therapies reported. It was reported that the patient received a second dose of PNEUMOVAX 23 six weeks after receiving the first dose. There were no adverse effects reported. There was no product quality complaint (PQC) involved. The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Rash developed starting at injection site, spreading to abdomen/chest/neck/back- red/raised- did not resolve until 12 hrs of benadryl Q6hrs
The client was given a Pfizer 12 year and up vaccine instead of Pedi Pfizer 5-11 years old.  No adverse symptoms. Mom made aware: the child was still in clinic waiting the 15 minutes after the vaccine.
5 days after upper lip swells, 10 day after shot lower lip swells - constant head ache, periodic nausea, body & joint aches, lower energy
I had swollen lymph nodes that started 09/04/2022 and a rash develop on my abdominal area. I started having severe joint pain and flu-like symptoms. I'm still having these symptoms currently. I called my doctor who suggested me to get a biopsy. I got the biopsy done on 11/10/2022; they said they couldn't determine any illnesses or infections based on the results and said I must've had a reaction to the vaccine. I also began losing my hair and inflammation. They also took blood for testing did a test for inflammation (SED rate test) on 10/12/2022, which came back with 100mm/h on the scale. They prescribed me hydroxychloroquine 200mg to be taken daily to try to help with my symptoms. I have a follow-up appointment in 3 months in March with my physician and an immunologist to conduct more tests. As of now waiting for my follow-up appointment, I'm doing okay; I'm still having the swollen lymph nodes, joint pain, and abdominal rash sometimes.
Received Pediarix, HIB, PCV7 on 08/16.  Temperature increased on 08/17 and 08/18, acted well.  No fever on 08/19 till evening:  fussy, temperature 100 degrees, continued with Tylenol.  No fever 08/22 AM, 100.8 degrees temperature in the evening.  Septic within normal limits.  Was happy throughout the evening 08/19.  On 08/24 see in doctors office with temperature 98.7, perfect.
Redness, soreness, swelling @ injection site, tiredness, nausea, low grade fever, chills, night sweats, muscle soreness, joint aches
Pt reported on 2/12/15 about a hypersensitivity reaction from ZOSTAVAX vaccination she got on 2/09. Patient said it looked pinkish and felt warm to the touch.
Severe swelling in left arm all way down. Fever - pain - took ice packs - Ibuprofen and went to bed. Stayed that way 3 days. Weakness.
Felt tired; Headache; Arm sore; patient tested positive and had the second dose of the vaccine; patient didn't have any chills or anything; patient tested positive and had the second dose of the vaccine; patient didn't have any chills or anything; This is a spontaneous report from a contactable consumer reported for self. This 57-year-old female patient received the first dose of BNT162B2 (Lot number ELD140, Expiry Date Mar2021) via unspecified route of administration on an unspecified date at single dose, and second dose of BNT162B2 (maybe the same Lot/ Expiry date as the first dose) via unspecified route of administration on 12Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that patient tested positive and had the second dose of the vaccine; patient didn't have any chills or anything. The patient clarified that she was tested positive at work. The patient had the nose swab 12Jan2021 at job and the patient had the second dose of the shot (vaccine). The patient stated that she felt tired in the morning and had headache and arm was sore, other than that the patient felt she was fine. The patient didn't have any chills or anything. The outcome of the events was unknown.
PATIENT REPORTING ITCHING AT 30 MINUTES POST INJECTION. AT 1.5 HOURS POST INJECTION PATIENT REPORTED ITCHY THROAT AND NUMBESS OF LEFT SIDE OF FACE. AT THAT TIME ADVISED TO GO TO EMERGENCY ROOM. NEXT DAY WHEN I FOLLOWED UP WITH PATIENT, SHE REPORTED HER AIRWAY STARTED TO CLOSE AND SHE RECEIVED EPINEPHRINE, AFTER 5 HOURS HER STARTED TO CLOSE AGAIN AND RECEIVED ANOTHER DOSE OF EPINEPHERINE, WAS RELEASED FROM HOSPITAL ROUGHLY 15-16 HOURS AFTER GOING TO ER.